These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6634151)

  • 1. [Adverse effect of drugs and difficulties in recognizing the cause-effect relationship].
    Orv Hetil; 1983 Aug; 124(33):2025. PubMed ID: 6634151
    [No Abstract]   [Full Text] [Related]  

  • 2. [Xerostomia as a side effect of drugs].
    Kelemen J; Nemes J
    Fogorv Sz; 1990 Sep; 83(9-10):277-81. PubMed ID: 2226959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The birth of new drugs].
    Petrányi G
    Orv Hetil; 1968 May; 109(21):Suppl:1-6. PubMed ID: 5720715
    [No Abstract]   [Full Text] [Related]  

  • 4. Bioequivalence and interchangeability of narrow therapeutic range drugs. Canadian Society for Pharmaceutical Sciences discussion.
    Palylyk-Colwell E; Jamali F; Dryden W; Friesen E; Koven S; Mohamed I; Osmond B; Alessi-Severini S; Sheldon L; Sheldon R; Tam Y; Tsuyuki R; Zhanel G
    J Pharm Pharm Sci; 1998; 1(1):2-7. PubMed ID: 10942966
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ophthalmologic side effects of some drugs with special reference to traffic regulations in Hungary].
    Márton D; Tözsér E
    Orv Hetil; 1966 Aug; 107(33):1559-60. PubMed ID: 5945675
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacovigilance: theoretical and practical aspects].
    Paoletti V; Galeotta G; Mammarella A
    Clin Ter; 1997 Mar; 148(3):67-73. PubMed ID: 9377842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug surveillance and the safety of drugs: guidelines for legislative and total cultural action].
    Laporte JR
    Rev Med Univ Navarra; 1988; 32(1):31-3. PubMed ID: 3175437
    [No Abstract]   [Full Text] [Related]  

  • 8. Regulating the fate of pharmaceutical drugs: a new prescription for the environment.
    Nidel CT
    Food Drug Law J; 2003; 58(1):81-101. PubMed ID: 12739585
    [No Abstract]   [Full Text] [Related]  

  • 9. The clinical pharmacologist in drug regulation: the US perspective.
    Temple RJ
    Br J Clin Pharmacol; 1996 Jul; 42(1):73-9. PubMed ID: 8807147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Difficulties and bias in attributing side effects to drugs].
    Weintraub M
    Nouv Presse Med; 1982 Oct; 11(40):3003-5. PubMed ID: 7145685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Status of side effects. 3. Intensified registration of adverse effects. What should be reported?].
    Myhr K; Lunde PK
    Tidsskr Nor Laegeforen; 1989 Nov; 109(31):3226-8. PubMed ID: 2595689
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drugs and fitness to drive].
    Ziegler R
    Med Monatsschr Pharm; 2007 Jan; 30(1):33-4. PubMed ID: 17260646
    [No Abstract]   [Full Text] [Related]  

  • 13. The learned intermediary doctrine: past, present and future.
    Alsobrook HB
    Leg Med; 1994; ():269-80. PubMed ID: 7830482
    [No Abstract]   [Full Text] [Related]  

  • 14. Extra-label drug use--pharmaceutical industry view.
    Welser JR
    J Am Vet Med Assoc; 1993 May; 202(10):1635-42;discussion 1654-8. PubMed ID: 8514571
    [No Abstract]   [Full Text] [Related]  

  • 15. [Liability for drug-related damage by the pharmaceutical industry and the physician].
    Dahse G
    Beitr Gerichtl Med; 1982; 40():21-2. PubMed ID: 7165639
    [No Abstract]   [Full Text] [Related]  

  • 16. The World Health Organization's prequalification program and its potential effect on data exclusivity laws.
    Childs DW
    Food Drug Law J; 2005; 60(1):79-97. PubMed ID: 15940855
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drugs for adults--and for the children?].
    Kalikstad B; Gramstad L
    Tidsskr Nor Laegeforen; 2005 Jun; 125(11):1470. PubMed ID: 15940308
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacovigilance: a case of phantom ships and Russian roulette].
    Stricker BH
    Ned Tijdschr Geneeskd; 2002 Jul; 146(27):1258-61. PubMed ID: 12138668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Some problems of drug distribution].
    Kempler K
    Orv Hetil; 1976 Sep; 117(36):2213-5. PubMed ID: 967427
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA attempting to overcome major roadblocks in monitoring drug safety.
    Zielinski SL
    J Natl Cancer Inst; 2005 Jun; 97(12):872-3. PubMed ID: 15956645
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.